2002
DOI: 10.3816/cbc.2002.s.019
|View full text |Cite
|
Sign up to set email alerts
|

Assessing Cognitive Dysfunction in Breast Cancer: What Are the Tools?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
54
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 52 publications
(55 citation statements)
references
References 19 publications
1
54
0
Order By: Relevance
“…Cognitive studies in cancer patients who have received chemotherapy are inconsistent in describing the types of NP dysfunction found, although commonly affected domains are attention/concentration, verbal and visual memory, and processing speed [4,[11][12][13][14][15][16][17][18]. Similar types of cognitive impairment have been identified in patients with early stage human immunodeficiency virus (HIV) infection [19,20], Huntington's disease [21], Parkinson's disease [22] and multiple sclerosis [23].…”
Section: Overview Of Cognitive Functioningmentioning
confidence: 95%
See 1 more Smart Citation
“…Cognitive studies in cancer patients who have received chemotherapy are inconsistent in describing the types of NP dysfunction found, although commonly affected domains are attention/concentration, verbal and visual memory, and processing speed [4,[11][12][13][14][15][16][17][18]. Similar types of cognitive impairment have been identified in patients with early stage human immunodeficiency virus (HIV) infection [19,20], Huntington's disease [21], Parkinson's disease [22] and multiple sclerosis [23].…”
Section: Overview Of Cognitive Functioningmentioning
confidence: 95%
“…Several small studies evaluating cognitive impairment after chemotherapy in solid tumour patients were published in the subsequent 25 years [31][32][33][34][35][36][37]. Larger studies have been performed in the last 10 years, although there are probably more reviews of cognitive impairment post chemotherapy [4,5,9,10,18,32,36, than original studies, and the available studies are predominantly in breast cancer survivors [11][12][13][14][15][16][17][18]51,[76][77][78][79][80][81][82][83][84]. Table 1 summarises the main cognitive studies that have been published in solid tumour patients and the incidence of cognitive impairment found.…”
Section: Overview Of the Literaturementioning
confidence: 99%
“…Several hours of testing may not be practical. In addition, in the context of a clinical trial, the time and expense Left hemisphere V i s u a l m e m o r y R i g h t h e m i s p h e r e Freeman 2002;Jansen et al , 2007 involved in extensive testing may preclude a complete examination from being included in the protocol (Freeman & Broshek). A multidisciplinary workshop held in 2004 yielded the suggestion of a two-stage approach to cognitive assessment, depending on the question that was being asked (Tannock et al, 2004).…”
Section: Challenges With Neurocognitive Testingmentioning
confidence: 99%
“…The array of neurocognitive tests that would normally be employed to conduct a full cognitive assessment may range in length from four to seven hours (Freeman & Broshek, 2002). Patient burden should be a consideration in determining the extent of testing that occurs in each session.…”
Section: Challenges With Neurocognitive Testingmentioning
confidence: 99%
See 1 more Smart Citation